From the Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine (Koch, Wang, Holladay), Houston, Texas, USA; Department of Ophthalmology, Shaare Zedek Medical Center, Affiliated to Hadasa Faculty of Medicine, The Hebrew University (Abulafia); Jerusalem, Israel, East Valley Ophthalmology (Hill), Mesa, Arizona, USA.
Corresponding author: Douglas D. Koch, MD, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin, NC 205, Houston, TX 77030. Email: [email protected].
Supported in part by Sid W. Richardson Foundation, Fort Worth, Texas, USA, and an unrestricted grant from Research to Prevent Blindness, New York, New York, USA (D.D. Koch and L. Wang).
Disclosures: Dr. Koch is a consultant for Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Johnson & Johnson Vision Care, Inc. Dr. Wang is a consultant for Carl Zeiss Meditec AG and Alcon Laboratories, Inc. Dr Abulafia is a consultant for Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Haag-Streit AG. Dr. Holladay is a consultant to Alcon Laboratories, Inc. and Carl Zeiss Meditec AG. The other author has a financial or proprietary interest in any material or method mentioned.
